The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.50
Ask: 20.15
Change: -0.51 (-2.55%)
Spread: 0.65 (3.333%)
Open: 19.50
High: 19.92
Low: 19.50
Prev. Close: 20.01
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Nanoco Group Plc

6 Dec 2019 12:00

RNS Number : 0473W
Peel Hunt LLP
06 December 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Nanoco Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Nanoco Group Plc

(d) Date dealing undertaken:

05 December 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

370,482

13.35 GBx

12.75 GBx

Ordinary Shares

Sell

215,765

13.80 GBx

12.92 GBx

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

06 December 2019

 

Contact name:

Paul Crispin

Telephone number:

0207 418 8988

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREAEAKEFNNFFF
Date   Source Headline
30th Jul 20187:00 amRNSDirectorate Changes
11th Jul 201812:07 pmRNSSecond Price Monitoring Extn
11th Jul 201812:02 pmRNSPrice Monitoring Extension
2nd Jul 201811:18 amRNSHolding(s) in Company
29th Jun 201811:50 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSDirectorate Change
8th Jun 20187:00 amRNSBlock listing Interim Review
15th May 20183:58 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSNanoco Announces Major Milestone Payment
2nd May 20187:00 amRNSLaunch of Nanoco 2D Materials Ltd
23rd Apr 20187:00 amRNSExpansion of Material Development Agreement
16th Apr 201811:41 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSHalf-year Results
15th Mar 201810:47 amRNSHolding(s) in Company
15th Mar 20187:00 amRNSNotice of Results
28th Feb 20182:34 pmRNSHolding(s) in Company
9th Feb 201812:59 pmRNSHolding(s) in Company
8th Feb 20187:00 amRNSMaterial Development and Supply Agreement
5th Feb 201812:39 pmRNSHolding(s) in Company
16th Jan 20184:45 pmRNSBLOCKLISTING SIX-MONTHLY RETURN
12th Jan 20182:48 pmRNSResult of AGM
12th Jan 20187:00 amRNSAGM Statement
2nd Jan 201812:07 pmRNSSecond Price Monitoring Extn
2nd Jan 201812:02 pmRNSPrice Monitoring Extension
29th Dec 201712:40 pmRNSSecond Price Monitoring Extn
29th Dec 201712:35 pmRNSPrice Monitoring Extension
19th Dec 20171:11 pmRNSHolding(s) in Company
18th Dec 20171:24 pmRNSHolding(s) in Company
12th Dec 201712:07 pmRNSSecond Price Monitoring Extn
12th Dec 201712:02 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSDirector/PDMR Shareholding
4th Dec 20177:00 amRNSCommercial Supply and License Agreement
30th Nov 20174:43 pmRNSSecond Price Monitoring Extn
30th Nov 20174:35 pmRNSPrice Monitoring Extension
30th Nov 201712:31 pmRNSHolding(s) in Company
30th Nov 20177:00 amRNSAnnual Financial Report
16th Nov 20174:50 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSPreliminary Results
15th Nov 201710:42 amRNSDirector/PDMR Shareholding
14th Nov 20171:38 pmRNSResult of General Meeting
14th Nov 20177:00 amRNSWebcast of Full Year Results
8th Nov 201712:08 pmRNSHolding(s) in Company
2nd Nov 201710:35 amRNSHolding(s) in Company
1st Nov 20177:00 amRNSNotice of Results
31st Oct 201711:11 amRNSHolding(s) in Company
26th Oct 20173:59 pmRNSPublication of Circular and Notice of GM
5th Oct 20177:00 amRNSResults of placing
4th Oct 20174:40 pmRNSProposed fundraising of £8.6 million
19th Sep 20173:13 pmRNSNanoco CFQD® Fine Color FilmT at Touch Taiwan 2017
8th Sep 201710:34 amRNSCommercial Supply and License Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.